Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G RAO

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cancer|March 1, 1981
Nitrite-induced volatile mutagens from normal human fecesB G Rao, I A MacDonald, D M Hutchison
Biochemical Pharmacology|December 1, 1987
Effects of membrane polyunsaturated fatty acids on opiate peptide inhibition of basal and prostaglandin E1-stimulated cyclic AMP formation in intact N1E-115 neuroblastoma cellsM G Murphy, C M Moak, B G Rao
Advances in Experimental Medicine and Biology|April 30, 1998
In vitro selection and characterization of VX-478 resistant HIV-1 variantsS Pazhanisamy, J A Partaledis, B G Rao, et al.
Experientia|June 15, 1984
Model systems demonstrating the volatile mutagenicity and carcinogenicity of sodium nitrite in ratsI A Macdonald, J A Mader, B G Rao, et al.
The Analyst|August 1, 1991
Colorimetric method for the determination of captafol (difolatan) in commercial formulations and residues on grains and applesB C Verma, D K Sharma, H K Thakur, et al.
Talanta|December 1, 1988
An oxidimetric method for the determination of thiophanatemethyl in commercial formulationsB C Verma, D K Sharma, H K Thakur, et al.
Journal of Virology|July 25, 2000
Structural and kinetic analyses of the protease from an amprenavir-resistant human immunodeficiency virus type 1 mutant rendered resistant to saquinavir and resensitized to amprenavirW Markland, B G Rao, J D Parsons, et al.
The Journal of Biological Chemistry|July 26, 1996
Kinetic characterization of human immunodeficiency virus type-1 protease-resistant variantsS Pazhanisamy, C M Stuver, A B Cullinan, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitorsC T Baker, F G Salituro, J J Court, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Design and synthesis of novel conformationally restricted HIV protease inhibitorsF G Salituro, C T Baker, J J Court, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer|March 1, 1981
Nitrite-induced volatile mutagens from normal human fecesB G Rao, I A MacDonald, D M Hutchison
Biochemical Pharmacology|December 1, 1987
Effects of membrane polyunsaturated fatty acids on opiate peptide inhibition of basal and prostaglandin E1-stimulated cyclic AMP formation in intact N1E-115 neuroblastoma cellsM G Murphy, C M Moak, B G Rao
Advances in Experimental Medicine and Biology|April 30, 1998
In vitro selection and characterization of VX-478 resistant HIV-1 variantsS Pazhanisamy, J A Partaledis, B G Rao, et al.
Experientia|June 15, 1984
Model systems demonstrating the volatile mutagenicity and carcinogenicity of sodium nitrite in ratsI A Macdonald, J A Mader, B G Rao, et al.
The Analyst|August 1, 1991
Colorimetric method for the determination of captafol (difolatan) in commercial formulations and residues on grains and applesB C Verma, D K Sharma, H K Thakur, et al.
Talanta|December 1, 1988
An oxidimetric method for the determination of thiophanatemethyl in commercial formulationsB C Verma, D K Sharma, H K Thakur, et al.
Journal of Virology|July 25, 2000
Structural and kinetic analyses of the protease from an amprenavir-resistant human immunodeficiency virus type 1 mutant rendered resistant to saquinavir and resensitized to amprenavirW Markland, B G Rao, J D Parsons, et al.
The Journal of Biological Chemistry|July 26, 1996
Kinetic characterization of human immunodeficiency virus type-1 protease-resistant variantsS Pazhanisamy, C M Stuver, A B Cullinan, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitorsC T Baker, F G Salituro, J J Court, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Design and synthesis of novel conformationally restricted HIV protease inhibitorsF G Salituro, C T Baker, J J Court, et al.
Pageof 2